Area for professionals

All about autoimmune encephalitis

Autoimmune encephalitis is a group of conditions in which the body’s immune system mistakenly attacks healthy brain cells, leading to inflammation of the brain. This disorder can affect people of all ages, though certain types are more common in young adults and children. Because the brain controls behaviour, memory, and bodily functions, inflammation can produce a wide range of symptoms that often appear suddenly and progress rapidly.


Common early signs include confusion, memory loss, and changes in personality or behaviour. Individuals may become anxious, paranoid, or experience hallucinations. As the condition advances, more severe neurological symptoms can develop, such as seizures, difficulty speaking, abnormal movements, or loss of consciousness. In some cases, patients may require intensive care due to complications affecting breathing or heart function.


Autoimmune encephalitis is often associated with antibodies that target specific proteins in the brain. One well-known form involves antibodies against NMDA (N-methyl-D-aspartate) receptors. These antibodies disrupt normal brain signalling, leading to the characteristic symptoms. The condition can sometimes be linked to tumours, particularly ovarian teratomas, though many cases occur without any identifiable trigger.


Diagnosis can be challenging because symptoms may resemble psychiatric disorders or viral infections. Doctors typically rely on a combination of clinical evaluation, brain imaging, spinal fluid analysis, and blood tests to detect specific antibodies. Early diagnosis is crucial, as prompt treatment significantly improves outcomes.


Treatment usually involves immunotherapy to reduce the immune system’s attack on the brain. This may include corticosteroids, intravenous immunoglobulin (IVIG), or plasma exchange. In cases associated with tumours, surgical removal is often necessary. With timely treatment, many patients recover well, though rehabilitation may be needed to address lingering cognitive or physical difficulties. Ongoing research continues to improve understanding and management of this complex condition.